Naltrexone hydrochloride (Naltrexone AOP) tab 50 mg: Supply issue resolved
Teva, the supplier of naltrexone hydrochloride tab 50 mg has advised that it is temporarily out of stock of Naltraccord (Pharmacode 2380374).
22 November 2023 Update
The registered product has arrived in New Zealand and released by the supplier. It may still take time for the product to make its way through the supply chain to pharmacies around the motu.
- Chemical: Naltrexone hydrochloride
- Presentation: Tab 50 mg
- Brand: Naltraccord
- Pharmacode: 2380374
- Special Authority SA1408(external link) -- Retail pharmacy
Teva secured 1,000 packs of an alternative product, Naltrexone AOP (Pharmacode 2664941). The alternative was not Medsafe approved and had to be prescribed and dispensed in line with section 29 of the Medicines Act.
The alternative was listed on the Pharmaceutical Schedule from 1 October 2023. The pack size was 28 tabs per pack and the price is equivalent to the Naltraccord brand (pro rata).
Prescribing and supplying an unapproved medicine
Section 29 of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – such as, a doctor.
We know supplying a medicine under section 29 is not ideal. In this case, however, this will allow patients to be able to access an appropriate treatment.
We apologise for any inconvenience this causes.
Resupplied November 2023
Teva received a shipment of Naltraccord in November. It has been released to the market.
Who to contact
If you have questions about this issue, email firstname.lastname@example.org
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.